Jefferies Group’s MacroGenics MGNX Stock Holding History

Jefferies Group’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-45,400	Closed	-$770K	–	2897
2019 Q2	$770K	Sell	45,400 -14,100	-24%	-$242K	0.01%	1435
2019 Q1	$1.07M	Buy	+59,500	New	+$1.03M	0.01%	1238

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Jefferies Group's MGNX Position: Q3 2020 in Review

Jefferies Group sold out of MacroGenics (MGNX) in Q3 2020, closing a stake of 1,961 shares — an estimated $55 sold.

Jefferies Group first reported a position in MGNX in Q1 2019 and held it in 5 quarters. The position peaked at $403K in Q3 2019. 139 funds tracked by Wall St. Rank hold MGNX as of Q3 2020.

Jefferies Group reported no remaining MacroGenics position as of Q3 2020 after selling out during the quarter.
Jefferies Group sold 1,961 MacroGenics shares in Q3 2020, an estimated $55.
Jefferies Group first reported a position in MacroGenics in Q1 2019 and held it in 5 quarters.
Jefferies Group's MacroGenics position peaked at $403K in Q3 2019.
139 funds tracked by Wall St. Rank held MacroGenics as of Q3 2020.

Based on Jefferies Group's 13F filing for Q3 2020, filed 13 Nov 2020.